By Nugra Septadi
Mesothelioma is a disease that affects cancer serous linings of various internal organs of the human body. These include the lungs, heart and the stomach are the most affected.
It is estimated that each year, 2000 new cases of mesothelioma are reported. Patients with tumors that had first exposure to asbestos, which is considered the only known cause of mesothelioma. Mesotheliomic patients are often told to survival in the short term, from 6 to 12 months. But doctors specialized in the treatment of malignant mesothelioma tumours in the main centres to expect better survival rates. While mesothelioma causes immense pain and suffering for the victim, along with short life expectancy, some treatments have successfully reducing and removing the cancerous tumor, mesothelioma.
Mesothelioma treatment depends on many factors, including the stage of cancer, the movement of malignant cells, pathology reports to determine the nature of cancer cells and age of the patient and health. Below is a detailed description of treatment options for mesothelioma.
CHEMOTHERAPY: Chemotherapy is a systematic treatment of mesothelioma using drugs, medicines and chemicals in an effective way to kill cancer cells. It is administered to patients in any way or pills is injected directly into the body. In some cases, drugs Entered are directly in the chest, known as intrapleural chemotherapy, or abdomen, known as intra peritoneal chemotherapy to destroy the growth of cancer cells. is also administered to patients before and after surgery to limit the growth of cancer mesothelioma.
Pemetrexed widely used, Alimta ®, is administered in combination of cisplatin (a standard platinum compounds) to treat pleural mesothelioma. The drug was approved by the EU Food and Drug Administration (FDA) in February 2004. The work of this drug is simple: you enter the blood of a patient and kill the cancer cells throughout the body, while blocking the growth of malignant cells. The drug has few side effects for which the vitamin B 12 and folic acid is administered to patients undergoing this treatment.
 |
http://meso-center.blogspot.com
No comments:
Post a Comment